Accelerate Diagnostics
AXDX
#10564
Rank
ยฃ0.64 M
Marketcap
ยฃ0.02550
Share price
0.00%
Change (1 day)
-98.09%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ63.45 Million

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are ยฃ63.45 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ40.23 M-44.23%
2022-12-31ยฃ72.14 M-17.56%
2021-12-31ยฃ87.5 M-23.66%
2020-12-31ยฃ0.11 B5.99%
2019-12-31ยฃ0.10 B7.33%
2018-12-31ยฃ0.10 B1900.1%
2017-12-31ยฃ5.03 M23.42%
2016-12-31ยฃ4.08 M-4.09%
2015-12-31ยฃ4.25 M73.89%
2014-12-31ยฃ2.44 M110.9%
2013-12-31ยฃ1.16 M
2012-07-31ยฃ1.51 M71.94%
2011-07-31ยฃ0.88 M1.96%
2010-07-31ยฃ0.86 M6.86%
2009-07-31ยฃ0.81 M13.45%
2008-07-31ยฃ0.71 M15.37%
2007-07-31ยฃ0.61 M4.73%
2006-07-31ยฃ0.59 M-21.99%
2005-07-31ยฃ0.75 M39.29%
2004-07-31ยฃ0.54 M-13.42%
2003-07-31ยฃ0.62 M-22.72%
2002-07-31ยฃ0.81 M3.46%
2001-07-31ยฃ0.78 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ38.90 B 61,210.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ4.95 B 7,706.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
ยฃ22.07 B 34,687.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
ยฃ2.21 B 3,398.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
ยฃ0.24 B 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
ยฃ2.95 B 4,560.39%๐Ÿ‡บ๐Ÿ‡ธ USA